![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205104
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206387
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204626
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204729
https://pharmaways.in/usfda-issues-8-observations-for-natco-pharma-hyderabad-unit/
https://www.moneycontrol.com/news/business/markets/ipca-pithampur-unit-in-minimally-acceptable-state-of-compliance-by-us-fda-11630311.html
https://www.fiercepharma.com/pharma/fda-slams-intas-ipca-trio-indian-manufacturing-write-ups
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-ipca-lab-india-79635.pdf
https://endpts.com/fda-says-ipca-labs-failed-to-address-quality-issues-with-bad-api-batches/
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-ipca-lab-74112.pdf